Δευτέρα 29 Ιουλίου 2019

Imatinib-Associated Pneumocystis jirovecii Pneumonia

Imatinib, sold under the brand names Gleevec among others, is a medication used to treat cancer. Specifically, it is used for chronic myelogenous leukemia and acute lymphocytic leukemia that are ... Wikipedia
Molar mass493.603 g/mol
FormulaC29H31N7O
Elimination half-life18 h (imatinib); 40 h (active metabolite)
ATC codeL01XE01 (WHO)
License dataEU EMA: by INNUS FDA: IMATINIB
Metabolismliver (mainly CYP3A4-mediated)


Imatinib-Associated Pneumocystis jirovecii Pneumonia in a Patient With Chronic Myeloid Leukemia

Daw, Jad BA1; Thapa, Bicky MD2; Chahine, Johnny MD2; Lak, Hassan MD2; Perez, Oscar MD2; Nair, Raunak MD2; Alomari, Mohammad MD2; Haddad, Abdo MD3
doi: 10.1097/MJT.0000000000000963
Letters to the Editor: PDF Only
BUY
PAP
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου